Vietnam's Diabetes Drug Market Insights
2 days ago
1 min read
Vietnam’s diabetes drug market is projected to reach USD 625.5 million by 2034, growing at a 5.85% CAGR. Demand is being driven by an aging population, urbanization, and sedentary lifestyles, with millions of Vietnamese people living with diabetes.
Livzon’s takeover of Imexpharm brings new R&D support and export access to a highly competitive market. However, out-of-pocket costs and uneven access outside Hanoi and HCMC could limit adoption of newer therapies.
Comments